Antonella Panzardi

Novel PET tracers to distinguish the nature of residual masses after the completion of chemotherapy in metastatic testicular germ cell tumours: A systematic review

Alessandro Bertocchi, Fabio De Vincenzo, Matteo Perrino, Nadia Cordua et autres

Abstract Background Testicular germ cell tumours (TGCTs) are the most common malignancy in young adult males. After chemotherapy, the evaluation of residual masses is critical. However, the current standard imaging modality, [ 18 F]-FDG PET, has limited specificity—particularly in distinguishing viable tumour …

it (code pays fourni par la source)

Dynamic, tumor-agnostic ctDNA analysis for MRD detection and longitudinal monitoring in pleural mesothelioma: The Janus-seq academic workflow.

Sergio Marchini, Micaela Piemontese, Luigi Cecchi, Laura Mannarino et autres

e20065 Background: Pleural mesothelioma (PM) is an aggressive thoracic malignancy with poor prognosis and limited tools for sensitive, real-time disease monitoring. Tissue biopsies are often invasive, difficult to obtain, and may not reflect tumor heterogeneity, while radiological imaging frequently detects progression late, …

it (code pays fourni par la source)

APOLLO11: a bio-data-driven model for clinical and translational research in lung cancer

Arsela Prelaj, Leonardo Provenzano, V. Miskovic, Monica Ganzinelli et autres

Identifying predictive and resistance biomarkers remains one of the most relevant unmet needs in clinical cancer research. Artificial Intelligence (AI) represents a powerful tool to develop predictive algorithms tailored to individual patients. Thanks to its ability to process large quantities of heterogeneous, …

it, us, gb (code pays fourni par la source)

From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching

Mariangela Gaudio, A. Floreani, Greta Schivardi, Domiziana Alaimo et autres

PurposePatients with HER2+ breast cancer (BC) can receive pertuzumab/trastuzumab (PT) subcutaneous (SC) or intravenous (IV) with similar efficacy. This study explores patients and healthcare professionals (HCPs) perceptions post-PT-SC implementation, alongside a pharmacoeconomic analysis.MethodsThis multicentre observational study included semi-structured interviews with HER2+ BC …

it (code pays fourni par la source)

P1.11.66 Cost-Effective Machine Learning for Predicting Survival in NSCLC Patients on Immunotherapy: Insights From the APOLLO11 Study

V. Miskovic, L. Mazzeo, Carlo Silvestri, A. Ferrarin et autres

it (code pays fourni par la source)

541P Switching from intravenous (IV) to subcutaneous (SC) pertuzumab trastuzumab (PT) in HER2+ breast cancer (BC): Final analysis of patients (pts), healthcare professional (HCPs), and pharmacoeconomic perspectives

Mariangela Gaudio, A. Floreani, G. Schivardi, Daniele Alaimo et autres

it (code pays fourni par la source)

Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay

Eleonora Vitali, Guido Valente, Antonella Panzardi, Alice Laffi et autres

it (code pays fourni par la source)

Dataset related to article "Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay"

Eleonora Vitali, Giulia Valente, Antonella Panzardi, Alice Laffi et autres

record contains raw data related to article " Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay" The finding of mTOR overactivation in patients affected by pancreatic neuroendocrine tumors (Pa-NETs) led to their treatment with …

it (code pays fourni par la source)

Dataset related to article "Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay"

Eleonora Vitali, Giulia Valente, Antonella Panzardi, Alice Laffi et autres

record contains raw data related to article " Pancreatic neuroendocrine tumor progression and resistance to everolimus: the crucial role of NF-kB and STAT3 interplay" The finding of mTOR overactivation in patients affected by pancreatic neuroendocrine tumors (Pa-NETs) led to their treatment with …

it (code pays fourni par la source)